Enzymes are biological polymers that catalyze the chemical reactions essential for life. They enable:
breakdown of nutrients to supply energy and building blocks
assembly of building blocks into proteins, DNA, membranes, cells, tissues
harnessing energy to power cell motility, neural function, and muscle contraction
With the exception of ribozymes (catalytic RNA), enzymes are proteins.
Activity of specific enzymes in body fluids or cell extracts aids in diagnosis and prognosis of disease.
Deficiencies in enzyme quantity or activity can result from:
genetic defects
nutritional deficits
toxins
Defective enzymes can arise from genetic mutations or infections (e.g., Vibrio cholerae).
Medical strategies target enzyme imbalances via:
pharmacologic inhibition of specific enzymes
potential gene therapy to correct deficits in enzyme levels or function
Enzymes have catalytic prowess, substrate specificity, and stereospecificity that extend roles beyond metabolism, including:
usage as soluble or immobilized catalysts in drug/antibiotic synthesis due to absolute stereospecificity
augmentation of detergents via proteolytic enzymes for dirt removal
production/enhancement of nutrient value in food (e.g., rennin for cheese; lactase for lactose intolerance)
Example: lactase deficiency leads to lactose intolerance; rennin (rennet) is used in cheese production.
Enzymes are Effective & Highly Specific Catalysts
Enzymes catalyze conversion of substrates to products, increasing rates relative to non-catalyzed reactions by at least a factor of 106.
Enzymes are not consumed or permanently altered by the reaction (they act as catalysts).
Enzymes are extremely selective for:
type of reaction catalyzed
a single substrate or a small set of related substrates
Enzymes are stereospecific, typically acting on one enantiomer only (e.g., D- vs L-sugars, L- vs D-amino acids).
Enzymes bind substrates via at least three attachment points, enabling catalytic orientation and, in some cases, conversion of nonchiral substrates to chiral products (e.g., pyruvate to L-lactate).
This exquisite specificity allows living cells to carry out many distinct chemical processes simultaneously.
Enzymes are Classified by Reaction Type
Common enzyme names describe the reaction type, ending with the suffix
-ase (e.g., dehydrogenases, proteases, isomerases).
Modifiers may precede the name to indicate substrate, source, regulation, or mechanism.
IUB nomenclature provides a unique name and code identifying reaction type and substrates, e.g., ATP:D-hexose 6-phosphotransferase for hexokinase (EC 2.7.1.1).
Enzymes are grouped into six classes:
Oxidoreductases (oxidations/reductions)
Transferases (transfer of moieties such as glycosyl, methyl, phosphoryl groups)
Hydrolases (hydrolytic cleavage of C–C, C–O, C–N, and other bonds)
Lyases (cleavage by atom elimination, forming double bonds)
Isomerases (rearrangements within a molecule)
Ligases (joining two molecules with ATP hydrolysis)
Despite IUB nomenclature, traditional names are still widely used.
Example: hexokinase is ATP:D-hexose 6-phosphotransferase (EC 2.7.1.1).
Prosthetic Groups, Cofactors, & Coenzymes in Catalysis
Nonprotein molecules/ions participate directly in substrate binding or catalysis:
prosthetic groups (tightly integrated into enzyme structure via covalent or noncovalent forces)
cofactors (loosely associated, reversible binding), sometimes required in the medium for catalysis
coenzymes (recyclable shuttles for substrates)
Prosthetic groups are tightly integrated; examples include:
pyridoxal phosphate, FMN, FAD, thiamin pyrophosphate, biotin, and metal ions (Co, Cu, Mg, Mn, Zn)
Metals are common prosthetic groups; metalloenzymes contain tightly bound metal ions.
Roles of metal ions in catalysis:
participate in redox reactions (often via heme or iron-sulfur clusters)
assist substrate binding/orientation, covalent bond formation with intermediates (e.g., Co2+ in coenzyme B12)
render substrates more electrophilic or nucleophilic
Cofactors can associate reversibly with enzymes or substrates; they must be present for catalysis.
Metal-activated enzymes require metal cofactors (as opposed to metalloenzymes with metal prosthetic groups).
Coenzymes shuttle groups (e.g., methyl groups, acyl groups, oligosaccharides) and stabilize unstable intermediates (e.g., hydride transfer).
Many coenzymes are derivatives of B vitamins:
NAD and NADP (nicotinamide-containing redox coenzymes)
FMN and FAD (riboflavin-derived redox coenzymes)
CoA (pantothenic acid derivative; carries acyl groups)
Thiamin (as thiamin pyrophosphate) participates in decarboxylation of α-keto acids
Folic acid and cobalamin (one-carbon metabolism)
The active site hosts cofactors/prosthetic groups necessary for catalysis.
Catalysis Occurs at the Active Site
Classical insight by Emil Fischer: enzymes and substrates form an enzyme–substrate (ES) complex with enhanced thermal stability.
The active site is typically a cleft or pocket; for multimeric enzymes, the active site can be at subunit interfaces.
The active site provides a 3D environment that shields substrates from solvent and facilitates catalysis; it also binds cofactors/prosthetic groups.
Substrates are oriented in close proximity to catalytic residues and cofactors to enable transformation into products.
The active site can bind cofactors/prosthetic groups essential for catalysis.
The Four General Mechanisms of Catalysis
Enzymes employ combinations of the following to drastically accelerate reactions:
Catalysis by Proximity
Binding substrates at the active site creates a region of high local substrate concentration and proper orientation, increasing reaction rate by at least ~10^3-fold.
This effect arises from increased effective collision frequency and proper alignment of reactive groups.
Acid–Base Catalysis
Ionizable groups in aminoacyl side chains or cofactors act as acids or bases.
Specific acid/base catalysis: only protons (H3O+) or OH− are involved; rate depends on proton concentration only.
General acid/base catalysis: rates depend on all acids/bases in solution or at the active site; broad proton donors/acceptors can contribute.
Catalysis by Strain (Transition State Stabilization via Conformational Change)
Enzymes bind substrates in a conformation slightly unfavorable for bond cleavage, mimicking the transition state and distorting bonds to facilitate cleavage.
Linus Pauling proposed transition-state stabilization as a general catalytic mechanism.
Covalent Catalysis
A reactive group of the enzyme forms a covalent bond with substrate, creating a transient modified enzyme that provides a new reaction pathway with a lower activation energy.
Common partners include cysteine, serine, and occasionally histidine.
Often follows a ping-pong mechanism where one substrate binds and is transformed before second substrate binds.
Examples illustrating these mechanisms:
Aspartic proteases (e.g., HIV protease) use acid–base catalysis with two conserved aspartates acting as general base and general acid.
Serine proteases (e.g., chymotrypsin) use covalent catalysis with a serine-195 residue forming an acyl-enzyme intermediate via a Ser–His–Asp charge-relay.
Fructose-2,6-bisphosphatase uses a catalytic triad and a covalent phosphohistidyl intermediate for hydrolysis.
Lock-and-key model was insufficient to explain flexibility during catalysis.
Induced fit model (Koshland) states substrates induce conformational changes in the enzyme, aligning catalytic residues and straining bonds to promote catalysis.
The enzyme and substrate mutually adjust, harnessing binding energy to drive transformation.
HIV Protease as a Canonical Aspartic Protease (Acid–Base Catalysis)
HIV protease uses two conserved aspartate residues in the active site (Asp X and Asp Y).
Mechanism:
Asp X acts as a general base to activate a water molecule by removing a proton, generating a nucleophile.
The activated water attacks the peptide carbonyl carbon, forming a tetrahedral transition state intermediate.
Asp Y acts as an acid to donate a proton to the amine generated by peptide bond cleavage, stabilizing the reaction and allowing product release.
The two aspartates can alternate roles depending on the catalytic stage, forming a coordinated acid–base relay.
Covalent Catalysis in Chymotrypsin and Related Serine Proteases
Chymotrypsin mechanism involves: covalent acyl-enzyme intermediate via a catalytic Ser195, aided by His57 and Asp102 (charge-relay network).
Steps include:
Activation of Ser195's hydroxyl by proton shuttling through His57 to Asp102, increasing Ser195 nucleophilicity.
Ser195 attacks substrate carbonyl, forming acyl-enzyme intermediate and releasing the amino terminal fragment.
A water molecule, activated by the charge-relay system, attacks the acyl-enzyme, forming a second tetrahedral intermediate.
Proton transfer restores Ser195 and releases the carboxyl terminal fragment.
Similar Ser-His-Asp catalytic triads exist in other proteases (trypsin, elastase) with variations in triad residues.
Fructose-2,6-Bisphosphatase: A Case of Covalent Catalysis with a Catalytic Triad
Fructose-2,6-bisphosphatase catalyzes hydrolysis of phosphate at C-2 of fructose-2,6-bisphosphate.
Active site features a catalytic triad: Glu and two His residues, with a covalent phosphohistidyl intermediate.
The mechanism involves transient covalent modification and subsequent hydrolysis to release phosphate.
This enzyme is a regulatory element in gluconeogenesis (Chapter 20).
Catalytic Residues Are Highly Conserved; Isozymes and Homology
Gene duplication can create paralogous enzymes that diverge to recognize different substrates (e.g., chymotrypsin vs trypsin).
Conserved residues indicate essential catalytic roles and substrate interactions.
Isozymes are distinct enzyme forms that catalyze the same reaction but differ in regulation, substrate affinity, or tissue distribution.
Isozymes arise from gene duplication and can provide backup or tissue-specific functionality.
Recent work enables single-molecule enzymology to observe catalytic events at the level of individual enzymes.
Single-Molecule Enzymology
Advances in nanotechnology/fluorescence microscopy allow observation of single enzyme–substrate events.
Enables measurement of individual catalytic steps and rates, revealing heterogeneity not captured in ensemble assays.
Enzyme Assays, High-Throughput Screening, & Drug Discovery
Enzyme assays detect catalytic activity to infer enzyme presence and concentration; under proper conditions, initial rates reflect enzyme quantity.
High-throughput screening (HTS) enables rapid testing of thousands of compounds for potential inhibitors/activators.
HTS uses robotics, optics, data processing, microfluidics; volumes typically 10–100 μL in plates with 96, 384, or 1536 wells.
Coupled assays and chromogenic/fluorescent readouts are favored for speed and automation.
Enzyme-linked immunosorbent assays (ELISAs) use antibodies linked to a reporter enzyme to detect non-catalytic proteins; readouts rely on substrate conversion producing measurable signals.
NAD(P)+-Dependent Dehydrogenases are often assayed spectrophotometrically by monitoring NAD(P)H absorption at 340 nm:
NAD(P)H absorbs at 340 nm, NAD(P)+ does not.
Changes in absorbance at 340 nm are proportional to enzyme activity.
Coupled enzyme assays are widely used when the target reaction does not yield a detectable signal directly (Figure 7–11):
A second dehydrogenase uses the product of the target enzyme as substrate, producing NAD(P)H which is measured at 340 nm.
P-nitrophenyl substrates provide simple colorimetric readouts after hydrolysis (e.g., p-nitrophenyl phosphate absorbs at 419 nm when dephosphorylated).
Enzyme discovery and development leverage these approaches to identify inhibitors with therapeutic potential; HTS platforms are used for combinatorial libraries.
Enzyme-Linked Immunoassays (ELISAs) & Related Immunoassays
Antibodies conjugated to reporter enzymes enable sensitive detection of antigens with no catalytic activity requirement.
ELISAs can quantify proteins in clinical samples after antigen capture and substrate conversion to a measurable label (colorimetric/fluorescent).
Enzyme-linked immunosorbent assays are a key tool for detecting proteins such as enzymes or nonenzymatic markers in plasma/serum.
Enzymes in Clinical Diagnosis: Cardiac Markers & Myocardial Infarction (MI)
Diagnostic windows: a marker should appear in plasma soon after MI to enable rapid diagnosis.
Early markers and their profiles:
Aspartate aminotransferase (AST/SGOT) and Alanine aminotransferase (ALT/SGPT) appeared early but were non-specific for cardiac tissue.
Lactate dehydrogenase (LDH) isozymes: LDH is a tetramer with two subunit types, H (heart) and M (muscle), producing five isozymes: I1 (HHHH), I2 (HHHM), I3 (HHMM), I4 (HMMM), I5 (MMMM).
CK-MB appears within 4–6 hours, peaks at 24 hours, returns to baseline by 48–72 hours.
Troponin (complex of three proteins: troponin I and T among others) is a highly sensitive and specific marker of cardiac muscle damage. Troponin I and T rise within 2–6 hours and remain elevated for 4–10 days.
Today, CK-MB and LDH are complemented or replaced by troponin measurements due to higher cardiac specificity and timing.
Enzyme activity assays for MI are interpreted with clinical context (age, sex, history, drug use, diagnostic specificity).
Other indicators include ischemia-modified albumin and broader proteomic panels.
The automated, high-throughput era allows rapid processing of many samples for MI diagnosis.
Enzymes in Clinical Chemistry: General Diagnostic Utility & Other Applications
Enzyme activity assays are used to assess organ function, tissue injury, and disease progression.
Key clinical enzymes include prostatic acid phosphatase (prostate cancer) and alkaline/acid phosphatases (bone and liver disorders).
Glucose measurement often uses enzyme-based assays (e.g., glucose oxidase).
Enzymes are used in therapy, such as tissue plasminogen activator (tPA) or streptokinase for thrombolysis in MI; trypsin has therapeutic uses in cystic fibrosis (see Chapter 54).
Enzymes for Genetic and Infectious Disease Diagnosis
Enzymes enable genetic diagnostics via restriction endonucleases that cut DNA at specific sequences.
Restriction fragment length polymorphisms (RFLPs) detect mutations that abolish or create restriction sites; used in prenatal diagnosis for conditions like sickle cell trait, beta-thalassemia, phenylketonuria, and Huntington’s disease (among others).
Polymerase chain reaction (PCR) uses a thermostable DNA polymerase to amplify defined DNA regions, enabling detection of small quantities of DNA and identification of pathogens.
Recombinant DNA technology enables study and production of enzymes:
Expression of cloned genes in E. coli or yeast; baculovirus system for cultured insect cells when post-translational processing is required.
GST fusion proteins can be purified using glutathione (GSH) affinity columns; proteolytic cleavage (e.g., thrombin) can remove tags to yield native enzyme.
Site-directed mutagenesis allows targeted amino acid substitutions to probe catalytic roles; combined with kinetics and X-ray crystallography, it reveals residues critical for catalysis/substrate binding.
Summary of recombinant techniques includes:
fusion proteins for purification
protease-mediated tag removal
site-directed mutagenesis for mechanistic insights
Practical and Theoretical Takeaways
Enzymes are extraordinary catalysts with high efficiency and stringent specificity, enabling complex regulation of metabolism and numerous cellular processes.
Catalytic strategies include proximity effects, acid-base catalysis, conformational strain, and covalent catalysis, often in combination.
Substrate binding can induce conformational changes in enzymes (induced fit), which enhances catalysis and specificity.
Enzymes link to clinical practice via diagnostics (MI markers, RFLP, ELISAs, proteomics) and therapeutics (tPA, protease inhibitors, enzyme therapies).
Understanding enzyme mechanism informs drug design through transition-state analog inhibitors and targeted mutagenesis.
High-throughput technologies and recombinant DNA methods have transformed enzyme research, enabling rapid discovery, characterization, and production of enzymatic tools.
Key Numerical References and Formulas
Enzymes can increase reaction rates by at least 106-fold compared to non-catalyzed reactions.
Diagnostic timing related to MI markers:
CK-MB: appears in 4–6 hours; peaks at 24 hours; returns to baseline by 48–72 hours.
Troponin I/T: rises within 2–6 hours; remains elevated for 4–10 days.
High-throughput screening specifics:
Typical volumes: 10−100μL per well.
Plate formats: 96-, 384-, or 1536-well plates.
Spectrophotometric readouts:
NADH/NADPH absorbance: peak at 340nm when reduced (NAD(P)H). Oxidized forms do not absorb at 340 nm.
p-nitrophenyl phosphate readout: absorbance at 419nm after hydrolysis.
Connections to Foundational Principles & Real-World Relevance
Enzyme specificity underpins drug discovery: transition-state analogs exploit knowledge of enzyme transition states to design potent inhibitors (e.g., HIV protease inhibitors).
The active site architecture demonstrates how structure dictates function; small changes in residues or cofactors can drastically alter activity.
Recombinant fusion proteins and affinity purification underpin modern biopharmaceutical production, enabling scalable enzyme manufacturing.
Enzyme assays are foundational in clinical diagnostics, enabling rapid, automated, and high-throughput assessment of organ dysfunction and disease progression.
Genetic diagnostics (RFLP, PCR) show how enzyme biology intersects with genomics to diagnose inherited conditions and infectious diseases.
Terminology Glossary (Key Terms)
ES complex: enzyme–substrate complex.
Active site: region of the enzyme that binds substrate and cofactors and facilitates catalysis.
Proximity catalysis: rate enhancement from bringing substrates into close proximity.
Acid-base catalysis: catalysis via proton donation/acceptance by catalytic residues or cofactors.
Covalent catalysis: transient covalent modification of the enzyme to facilitate reaction.
Induced fit: substrate binding induces conformational changes that enhance catalysis.
Isozymes: different forms of an enzyme that catalyze the same reaction but differ in properties.
RFLP: restriction fragment length polymorphism, a genetic diagnostic tool.
HTS: high-throughput screening, rapid testing of many compounds for activity.
ELISA: enzyme-linked immunosorbent assay, immunological detection using enzyme reporters.
Coenzyme: recyclable substrate shuttle that carries groups (e.g., NAD+, FAD, CoA).
Prosthetic group: nonprotein moiety tightly integrated into an enzyme.
Metalloenzyme: enzyme with a tightly bound metal ion as a cofactor or prosthetic group.
Ping-pong mechanism: alternating substrate binding and product release with a catalytic intermediate.
Catalytic triad: a set of three residues that cooperate to catalyze a reaction (examples include Ser-His-Asp or Glu-His-His).
Transition state analog: inhibitor designed to resemble the transition state of a catalyzed reaction.
Summary of Core Takeaways
Enzymes are among the most efficient and specific catalysts, enabling life's chemistry by dramatically increasing reaction rates without being consumed.
They use diverse catalytic strategies and undergo conformational changes to optimize catalysis; the active site environment and cofactors are central to function.
The study of enzymes spans basic science (mechanisms, structure–function) and clinical applications (diagnosis, prognosis, therapeutics, and drug discovery).
Modern techniques (HTS, recombinant DNA, site-directed mutagenesis, single-molecule studies) empower both fundamental understanding and practical applications, including high-throughput drug screening and precision diagnostics.